Please assess the completion status of the following clinical trial:

Trial Title: Anesthesia With Propofol, Dexmedetomidine and Lidocaine Infusions for Laparoscopic Cholecystectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* American Society of Anesthesiologists I-II patients~* 20-60 years~Exclusion Criteria:~* American Society of Anesthesiologists III and above patients~* BMI: 35 and above~* Hepatic, renal or cardiac insufficiency~* 2 degree Heart block and above~* Diabetes~* Psychiatric disease~* History of chronic pain~* Alcohol or drug abuse~* Allergy to any of a drug in the study groups~* Pregnant, breast-feeding or menstruating women~* Inability to use a patient-controlled analgesia device~* Any analgesic or antiemetic use in last 24 hours before anesthesia induction~* Any surgical complication that may affect the outcomes of the study (open surgery etc.)

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Opiod-free group (Type: OTHER): Opioid-free anesthesia (Group DL) with dexmedetomidine (0.6 mg/kg loading, 0.3 mg/kg/h infusion), lidocaine (1.5 mg/kg loading, 2 mg/kg/h infusion), and propofol infusions (3-12 mg/kg/h).
- Opioid-based group (Type: OTHER): Opioid-based anesthesia (Group RF) with single dose fentanyl (2μg/kg), remifentanil (0.25μg/kg/min), and propofol infusions (3-12 mg/kg/h).

Based on this trial design, predict the completion outcome and termination type (if applicable).